BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20602619)

  • 1. Pharmacogenetics of tomorrow: the 1 + 1 = 3 principle.
    Pander J; Wessels JA; Mathijssen RH; Gelderblom H; Guchelaar HJ
    Pharmacogenomics; 2010 Jul; 11(7):1011-7. PubMed ID: 20602619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetic studies of epilepsy drugs: are we there yet?
    Spurr NK
    Trends Genet; 2006 May; 22(5):250-2. PubMed ID: 16564110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the use of multifactor dimensionality reduction (MDR) and classification and regression tree (CART) to identify haplotype-haplotype interactions in genetic studies.
    Hsieh AR; Hsiao CL; Chang SW; Wang HM; Fann CS
    Genomics; 2011 Feb; 97(2):77-85. PubMed ID: 21111805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics: the Dx perspective.
    Cartwright CP
    Expert Rev Mol Diagn; 2001 Nov; 1(4):371-6. PubMed ID: 11901851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of pharmacogenetics in cancer therapeutics.
    Yong WP; Innocenti F; Ratain MJ
    Br J Clin Pharmacol; 2006 Jul; 62(1):35-46. PubMed ID: 16842377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combinatorial pharmacogenetics.
    Wilke RA; Reif DM; Moore JH
    Nat Rev Drug Discov; 2005 Nov; 4(11):911-8. PubMed ID: 16264434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug receptor/effector polymorphisms and pharmacogenetics: current status and challenges.
    Johnson JA; Lima JJ
    Pharmacogenetics; 2003 Sep; 13(9):525-34. PubMed ID: 12972951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-loci analysis reveals the importance of genetic variations in sensitivity of platinum-based chemotherapy in non-small-cell lung cancer.
    Liu L; Wu J; Zhong R; Wu C; Zou L; Yang B; Chen W; Zhu B; Duan S; Yu D; Tan W; Nie S; Lin D; Miao X
    Mol Carcinog; 2013 Dec; 52(12):923-31. PubMed ID: 22821704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interpreting P values in pharmacogenetic studies: a call for process and perspective.
    Maitland ML; Ratain MJ; Cox NJ
    J Clin Oncol; 2007 Oct; 25(29):4513-5. PubMed ID: 17925544
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacogenetics in biological perspective.
    Kalow W
    Pharmacol Rev; 1997 Dec; 49(4):369-79. PubMed ID: 9443163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward understanding genetic risk for differential antipsychotic response in individuals with schizophrenia.
    Arranz MJ; Munro JC
    Expert Rev Clin Pharmacol; 2011 May; 4(3):389-405. PubMed ID: 22114782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fundamentals of pharmacology and applications in pharmacogenetics.
    Al-Ghoul M; Valdes R
    Clin Lab Med; 2008 Dec; 28(4):485-97. PubMed ID: 19059057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetics in drug discovery and development: a translational perspective.
    Roses AD
    Nat Rev Drug Discov; 2008 Oct; 7(10):807-17. PubMed ID: 18806753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetics of osteoporosis: future perspectives.
    Marini F; Brandi ML
    Calcif Tissue Int; 2009 May; 84(5):337-47. PubMed ID: 19271099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacogenetics in pediatric patients.
    Husain A; Loehle JA; Hein DW
    Pharmacogenomics; 2007 Oct; 8(10):1403-11. PubMed ID: 17979513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics: practices and opportunities for study design and data analysis.
    Flynn AA
    Drug Discov Today; 2011 Oct; 16(19-20):862-6. PubMed ID: 21875683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of pharmacogenomics.
    Somogy A
    Proc West Pharmacol Soc; 2008; 51():1-4. PubMed ID: 19544663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Race, ethnicity, ancestry, and pharmacogenetics.
    Urban TJ
    Mt Sinai J Med; 2010; 77(2):133-9. PubMed ID: 20309922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical applications of pharmacogenetics in psychiatry.
    Staddon S; Arranz MJ; Mancama D; Mata I; Kerwin RW
    Psychopharmacology (Berl); 2002 Jun; 162(1):18-23. PubMed ID: 12107612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A roadmap to multifactor dimensionality reduction methods.
    Gola D; Mahachie John JM; van Steen K; König IR
    Brief Bioinform; 2016 Mar; 17(2):293-308. PubMed ID: 26108231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.